GAMIDA CELL LTD., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 20__ Debt SecuritiesIndenture • September 13th, 2021 • Gamida Cell Ltd. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 13th, 2021 Company Industry JurisdictionIndenture, dated as of [●], 20__, among Gamida Cell Ltd., a company organized under the laws of the State of Israel under company number 51-260120-4 and having its registered office at 5 Nahum Heftsadie Street Givaat Shaul, Jerusalem 91340 Israel (the “Company”), and [Trustee], as trustee (the “Trustee”):
OPEN MARKET SALE AGREEMENTSMOpen Market Sale Agreement • September 13th, 2021 • Gamida Cell Ltd. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 13th, 2021 Company Industry JurisdictionGamida Cell Ltd., a limited liability company organized under the laws of the State of Israel (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s ordinary shares with a nominal value of New Israeli Shekel 0.01 per share (the “Ordinary Shares”), on the terms set forth in this agreement (this “Agreement”).